SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-027037
Filing Date
2024-02-23
Accepted
2024-02-23 16:17:01
Documents
15
Period of Report
2024-02-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm246865d1_8k.htm   iXBRL 8-K 25412
2 EXHIBIT 3.1 tm246865d1_ex3-1.htm EX-3.1 5699
  Complete submission text file 0001104659-24-027037.txt   207525

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxi-20240220.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20240220_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20240220_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT tm246865d1_8k_htm.xml XML 3713
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 24671424
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)